CABG [clinicaltrials_resource:NCT00114972/group/E1]
Coronary Artery By-pass Graft (CABG)
Reported events for NCT00114972 [clinicaltrials_resource:121528dba9912543511ab827b7b255ea]Total, other adverse events for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/other_events/54/count/107]Anaemia for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/other_events/55/count/109]Angina pectoris for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/other_events/56/count/111]Atrial fibrillation for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/other_events/57/count/113]All other Adverse Events for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/other_events/58/count/115]Wound infection for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/other_events/59/count/117]Incision site complication for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/other_events/60/count/119]Pleural effusion for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/other_events/61/count/121]Total, serious adverse events for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/1/count/1]Cardiac Arrest for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/10/count/19]Cardiac Failure for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/11/count/21]Cardiac Failure Congestive for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/12/count/23]Cardiac tamponade for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/13/count/25]Cardiogenic Shock for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/14/count/27]Coronary Artery Thrombosis for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/15/count/29]Myocardial Ischaemia for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/16/count/31]Pericardial Effusion for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/17/count/33]Vertigo Positional for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/18/count/35]Basedow's Disease for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/19/count/37]Anaemia for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/2/count/3]Cataract, lens disorder, renal detachment for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/20/count/39]Gastrointestinal Haemorrhage for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/21/count/41]Other gastrointestinal disorders for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/22/count/43]Catheter site haematoma for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/23/count/45]Non-cardiac chest pain for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/24/count/47]Other general disorders and administration site conditions for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/25/count/49]Hepatobiliary disorders for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/26/count/51]Anaphylactic shock , reaction and drug hypersensitivity for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/27/count/53]Infection and abcess for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/28/count/55]Pneumonia for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/29/count/57]coagulopathy, iron deficiency anaemia, leukocytosis, thrombocyopenia for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/3/count/5]Sepsis for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/30/count/59]Wound infection for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/31/count/61]Injury and procedural complications for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/32/count/63]Post procedural haemorrhage for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/33/count/65]Vascular graft occlusion for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/34/count/67]Abnormal blood test values for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/35/count/69]Cardiac enzymes increased for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/36/count/71]Metabolism and nutrition disorders for NCT00114972 for E1 in NCT00114972 [clinicaltrials_resource:NCT00114972/serious_events/37/count/73]
group [clinicaltrials_vocabulary:group]
CABG [clinicaltrials_resource:NCT00114972/group/E1]
Coronary Artery By-pass Graft (CABG)
Bio2RDF identifier
NCT00114972/group/E1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00114972/group/E1
group id [clinicaltrials_vocabulary:group-id]
description
Coronary Artery By-pass Graft (CABG)
@en
identifier
clinicaltrials_resource:NCT00114972/group/E1
title
CABG
@en
type
label
CABG [clinicaltrials_resource:NCT00114972/group/E1]
@en